NASDAQ:PRENW Prenetics Global (PRENW) Stock Price, News & Analysis → 917 Trades… Zero Losses? (From Insiders Exposed) (Ad) Free PRENW Stock Alerts $0.01 -0.01 (-36.90%) (As of 02:23 PM ET) Add Compare Share Share Today's Range$0.0101▼$0.015050-Day Range$0.0057▼$0.016852-Week Range$0.00▼$0.13Volume101,290 shsAverage Volume102,442 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends Get Prenetics Global alerts: Email Address Ad InvestorPlaceNext-Gen AI is Creating Millionaires Right NowI predict massive unemployment is coming. 800 million could lose their jobs, according to a McKinsey study, and 70% of all existing occupations could see a pay cut because of job elimination, according to Wired magazine.Here’s what I’m recommending now (includes 2 stock tickers). About Prenetics GlobalPrenetics Global Limited operates as a diagnostics and genetic testing company in Hong Kong and the United Kingdom. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring device that offers COVID-19 testing solutions for professional use and home use. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; ACTOnco, a comprehensive test that helps clinicians choose the optimal treatment for all major solid tumors; ACTDrug+, a screening test that checks for 40 cancer genes to map drug options and provide treatment strategy options; ACTLung, a test focused on biomarkers associated with lung cancer for targeted therapy; ACTFusion, a test that decodes 13 fusion genes and more than 350 transcripts to map drug options; and ACTCerebra, a genomic profiling service for solid tumors. It also offers ACTMonitor, a test that analyzes 50 forms of circulating tumor DNA in the bloodstream; and ACT Risk, a screening of 67 cancer genes associated with 9 common hereditary cancers and 11 cancer syndromes. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.Read More PRENW Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PRENW Stock News HeadlinesJune 17, 2024 | americanbankingnews.comPrenetics Global Limited (NASDAQ:PRENW) Short Interest Down 16.4% in MaySee More Headlines Receive PRENW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Prenetics Global and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolNASDAQ:PRENW CUSIPN/A CIK1876431 Webwww.prenetics.com Phone852 2210 9588FaxN/AEmployees400Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$23.23 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Sheng Wu Yeung (Age 45)Co-Founder & CEO Dr. Chi Hung Tzang Ph.D. (Age 49)Co-Founder, Chief Scientific Officer & Member of Scientific Advisory Board Mr. Hoi Chun Lo (Age 39)Chief Financial Officer Dr. Yung Ho Wong DPHIL (Age 42)Chief Technology Officer Ms. Yvonne L. WongChief Corporate Development OfficerMs. Samantha KwokVice President People & CultureDr. Senthil Sundaram M.D. (Age 50)Chief Clinical Officer Mr. Avrom Boris Lasarow (Age 47)Chief Executive Officer of EMEA Dr. Shih-Chang Ong M.D. (Age 46)Chief Medical Officer & Member of Scientific Advisory Board Mr. Joel NeohChief Consumer Officer & MD for CircleDNAMore ExecutivesKey CompetitorsbioAffinity TechnologiesNASDAQ:BIAFWSeqLLNASDAQ:SQLLWStar EquityNASDAQ:STRRP180 Life SciencesNASDAQ:ATNFW60 Degrees PharmaceuticalsNASDAQ:SXTPWView All Competitors PRENW Stock Analysis - Frequently Asked Questions How have PRENW shares performed in 2024? Prenetics Global's stock was trading at $0.01 at the start of the year. Since then, PRENW shares have increased by 6.0% and is now trading at $0.0106. View the best growth stocks for 2024 here. Are investors shorting Prenetics Global? Prenetics Global saw a decline in short interest during the month of May. As of May 31st, there was short interest totaling 12,700 shares, a decline of 16.4% from the May 15th total of 15,200 shares. Based on an average trading volume of 15,400 shares, the short-interest ratio is presently 0.8 days. View Prenetics Global's Short Interest. How do I buy shares of Prenetics Global? Shares of PRENW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PRENW) was last updated on 6/26/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredLoophole for Biden’s New Digital Currency PlanHave you heard about Executive Order 14067? This lesser-known order introduced the Digital Dollar, an alarming...Golden Crest | SponsoredSilver Expected for Extreme Price ActionOur newest Silver Investing Guide reveals how savvy investors are capitalizing on silver's continued rise – PL...Colonial Metals | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine...InvestorPlace | SponsoredCatalyst Could Trigger 10,000% Crypto GainsFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prenetics Global Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Prenetics Global With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.